Methylprednisolone suppresses the Wnt signaling pathway in chronic lymphocytic leukemia cell line MEC-1 regulated by LEF-1 expression.
Methylprednisolone suppresses the Wnt signaling pathway in chronic lymphocytic leukemia cell line MEC-1 regulated by LEF-1 expression.
复制标题
Mmethylprednisolone 抑制慢性淋巴细胞白血病细胞系 MEC-1 中受 LEF-1 表达调节的 Wnt 信号通路。
DOI:
--
复制
发表时间:
2015-07
期刊:
影响因子:
--
通讯作者:
Wang, Xin
中科院分区:
文献类型:
--
作者:
Liu, Yan-Xia;Zhang, Feng;Yuan, Ting;Wang, Xin
High dose methylprednisolone (HDMP) has been an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia (CLL), while little is known about the exact mechanisms implicated in glucocorticoid-induced cell death. To explore the mechanism of glucocorticoid-induced cell death, we investigated the effect of HDMP on canonical Wnt signaling which emerged as a key pathway implicated in the pathogenesis of CLL. In this study, the human CLL cell line MEC-1 was incubated with various concentrations of methylprednisolone. Cell proliferation activity was detected by CCK8 assay, the apoptotic effect was evaluated by TUNEL assay. Western blot was used to detect active-caspase 3, and the key proteins in Wnt signaling pathway (LEF-1, β-catenin). RT-PCR was performed to assess the mRNA levels of β-catenin, LEF-1, c-myc and cyclin D1. We observed that high concentration of methylprednisolone could suppress the proliferation activity of MEC-1 cells, promote the relative expression of active-caspase 3, and induce apoptotic cell death. Furthermore, methylprednisolone could inhibit LEF-1 protein expression, consequently down-regulate mRNA levels of c-myc and cyclin D1, but could not affect the transcription level of β-catenin and LEF-1 mRNA. The results of this study indicate that methylprednisolone can suppress Wnt signaling pathway by down-regulating LEF-1 protein expression, indicating a novel mechanism for HDMP therapy in CLL.
登录
查看更多内容
影响因子:
3.6
作者:
Chen, Jiezhong;McMillan, Nigel A. J.
通讯作者:
McMillan, Nigel A. J.
影响因子:
20.3
作者:
Andrea L. Rose;Barbara E. Smith;D. Maloney
通讯作者:
Andrea L. Rose;Barbara E. Smith;D. Maloney
影响因子:
4
作者:
K. Wallace;Carylyn J. Marek;S. Hoppler;M. Wright
通讯作者:
K. Wallace;Carylyn J. Marek;S. Hoppler;M. Wright
影响因子:
4.8
作者:
R. Gandhirajan;P. Staib;Katharina Minke;I. Gehrke;Günther Plickert;Axel Schlösser;E. Schmitt;M. Hallek;K. Kreuzer
通讯作者:
R. Gandhirajan;P. Staib;Katharina Minke;I. Gehrke;Günther Plickert;Axel Schlösser;E. Schmitt;M. Hallek;K. Kreuzer
DOI:
10.1172/jci22094
发表时间:
2005-02
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
Antonella Contri;A. Brunati;L. Trentin;A. Cabrelle;M. Miorin;L. Cesaro;L. Pinna;R. Zambello;G. Semenzato;A. Donella‐Deana
通讯作者:
Antonella Contri;A. Brunati;L. Trentin;A. Cabrelle;M. Miorin;L. Cesaro;L. Pinna;R. Zambello;G. Semenzato;A. Donella‐Deana